Ascendis Pharma A/S Overview
Ascendis Pharma A/S Target Price
Analysts' 12-month price predictions for ASND.
Share Price
$205.91
Average Target Price
$230.00
11.7% upside
11.7% upside1 analysts in the last 4 months
High: $230 | Low: $230
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-08 | RBC CapitalLuca Issi | $230 | 11.7% upside |  |
| 2025-02-18 | Morgan Stanley | $180 |  12.6% downside | |
| 2024-09-23 | Bank of America SecuritiesTazeen Ahmad | $191 | 7.2% downside | |
| 2024-09-17 | Evercore ISIGavin Clark-Gartner | $205 | 0.4% downside | |
| 2024-09-17 | OppenheimerLeland Gershell | $190 | 7.7% downside | |
| 2024-09-17 | CitigroupDavid Lebowitz | $207 | 0.5% upside | |
| 2024-09-17 | Wells FargoDerek Archila | $289 | 40.4% upside | |
| 2024-09-16 | Bank of America SecuritiesTazeen Ahmad | $175 | 15% downside | |
| 2024-09-16 | Goldman SachsPaul Choi | $200 | 2.9% downside | |
| 2024-09-13 | CitigroupDavid Lebowitz | $178 | 13.6% downside | |
| 2024-09-05 | OppenheimerLeland Gershell | $180 | 12.6% downside | |
| 2024-08-13 | JefferiesKelly Shi | $196 | 4.8% downside | |
| 2024-05-30 | Stifel NicolausAlex Thompson | $200 | 2.9% downside | |
| 2024-05-15 | Morgan StanleyVikram Purohit | $140 | 32% downside | |
| 2024-03-14 | Evercore ISIJosh Schimmer | $191 | 7.2% downside | |
| 2023-01-03 | Wells Fargo | $177 | 14% downside | |
| 2022-11-15 | Morgan Stanley | $148 | 28.1% downside | |
| 2022-11-14 | Leerink Partners | $148 | 28.1% downside | |
| 2022-11-14 | Wedbush | $164 | 20.4% downside | |
| 2022-03-20 | Bank of America SecuritiesTazeen Ahmad | $161 | 21.8% downside | |
| 2022-02-28 | CitigroupDavid Lebovitz | $187 | 9.2% downside | |
| 2022-01-06 | Cowen & Co.Yaron Werber | $136 | 34% downside | |
| 2021-07-07 | Canaccord GenuityMichelle Gilson | $196 | 4.8% downside | |
| 2021-06-14 | Cantor FitzgeraldAlethia Young | $201 | 2.4% downside | |